AD/PD 2026: Novo Nordisk’s semaglutide fails to demonstrate any benefit for early Alzheimer’s
On March 19, at the AD/PD 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders, during a…
Analyst Comment
TB or not TB: WHO releases new TB diagnostic guidelines ahead of World TB Day
Population patterns of CKD: the role of age and sex
Silent spread, serious consequences: the shifting trends of AMR
Kidney disease risk higher after Covid infection than after influenza infection
Largest study of vegetarian diets to date shows reduced risk of five cancers
Illicit drug use associated with increased odds of stroke
Preclinical data for MDL-001 indicates potential across multiple viral infections
